Understanding influenza vaccine protection in the community: An assessment of the 2013 influenza season in Victoria, Australia

Vaccine

Volumn 33, Issue 2, 2015, Pages 341-345

  Carville, Kylie S ^a   Grant, Kristina A ^a   Sullivan, Sheena G ^a   Fielding, James E ^a   Lane, Courtney R ^a,b   Franklin, Lucinda ^c   Druce, Julian ^a   Kelly, Heath A ^a,b  

^a PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

^b The Australian National University   (Australia)

^c DEPARTMENT OF PRIMARY INDUSTRIES   (Australia)

Author keywords

Influenza; Influenza season; Influenza vaccine; Influenza like illness; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGE; ARTICLE; AUSTRALIA; COMORBIDITY; CONSULTATION; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; EPIDEMIC; FEMALE; GENERAL PRACTITIONER SENTINEL SURVEILLANCE; HEALTH PROGRAM; HOSPITAL ADMISSION; HUMAN; INFLUENZA A; INFLUENZA B; INFLUENZA COMPLICATIONS ALERT NETWORK; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; NATIONAL HOME DOCTOR SERVICE; PRIORITY JOURNAL; SEASONAL INFLUENZA; SENTINEL SURVEILLANCE; CASE CONTROL STUDY; EPIDEMIOLOGY; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; INFLUENZA, HUMAN; MIDDLE AGED; ODDS RATIO; SEASON; TIME; VACCINATION; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; ODDS RATIO; SEASONS; SENTINEL SURVEILLANCE; TIME FACTORS; VACCINATION; VICTORIA; YOUNG ADULT;

EID: 84922368531     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.11.019     Document Type: Article

References (26)

1. Turner R.B. The common cold. Principles and practice of infectious diseases 2010, 809-813. Churchill Livingstone Elsevier, Philadelphia, PA. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
2. Australian Government Department of Health and Ageing Australian influenza report [database on the Internet] 2013, Australian Government Department of Health and Ageing, Available from: https://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-ozflu-flucurr.htm [cited 14 March 2014].
3. Australian Government Department of Health and Ageing. Influenza (Flu). Canberra: Australian Government Department of Health and Ageing; [cited 2014 14 Mar]; Available from: http://health.gov.au/internet/immunise/publishing.nsf/Content/immunise-influenza
4. WHO. Recommended composition of influenza virus vaccines for use in the 2013 southern hemisphere influenza season. Wkly Epidemiol Rec 2012;87(41):389-400.
5. Kelly H., Carville K., Grant K., Jacoby P., Tran T., Barr I. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One 2009, 4(3):e5079.
6. Fielding J.E., Grant K.A., Garcia K., Kelly H.A. Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010. Emerg Infect Dis 2011, 17(7):1181-1187.
7. Sullivan S.G., Komadina N., Grant K., Jelley L., Papadakis G., Kelly H. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match. J Med Virol 2014, 86(6):1017-1025.
8. Kelly H.A., Sullivan S.G., Grant K.A., Fielding J.E. Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. Influenza Other Respir Viruses 2013, 7(5):729-737.
9. Thursky K., Cordova S.P., Smith D., Kelly H. Working towards a simple case definition for influenza surveillance. J Clin Virol 2003, 27(2):170-179.
10. Kelly P.M., Kotsimbos T., Reynolds A., Wood-Baker R., Hancox B., Brown S.G., et al. FluCAN 2009: initial results from sentinel surveillance for adult influenza and pneumonia in eight Australian hospitals. Med J Aust 2011, 194(4):169-174.
11. Cheng A.C., Flu C.A.N.I. Hospitalisation with confirmed influenza in a sentinel surveillance system in 2010 and 2011. Med J Aust 2012, 197(4):217.
12. Hobson D., Curry R.L., Beare A.S., Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972, 70(4):767-777.
13. Foppa I.M., Haber M., Ferdinands J.M., Shay D.K. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013, 31(30):3104-3109.
14. Jackson M.L., Nelson J.C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31(17):2165-2168.
15. Azur M.J., Stuart E.A., Frangakis C., Leaf P.J. Multiple imputation by chained equations: what is it and how does it work?. Int J Methods Psychiatr Res 2011, 20(1):40-49.
16. Fielding J., Grant K., Franklin L., Sullivan S., Papadakis G., Kelly H., et al. Epidemiology of the 2012 influenza season in Victoria, Australia. West Pac Surveill Resp 2013, 4(3):42-50.
17. Kissling E., Valenciano M., Buchholz U., Larrauri A., Cohen J., Nunes B., et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill 2014, 19(6).
18. Flannery B., Thaker S.N., Clippard J., Monto A.S., Ohmit S.E., Zimmerman R.K., et al. Interim estimates of 2013-14 seasonal influenza vaccine effectiveness-United States, February 2014. Morb Mortal Wkly Rep 2014, 63(7):137-142.
19. Skowronski D., Chambers C., Sabaiduc S., De Serres G., Dickinson J., Winter A., et al. Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. Euro Surveill 2014, 19(5).
20. Fielding J., Grant K., Tran T., Kelly H. Moderate influenza vaccine effectiveness in Victoria, Australia, 2011. Euro Surveill 2012, 17(11). (pii=20115).
21. Cheng A.C., Dwyer D.E., Holmes M., Irving L.B., Brown S.G., Waterer G.W., et al. Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2013: the Influenza Complications Alert Network. Commun Dis Intell 2014, 38(2):E143-E149.
22. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12(1):36-44.
23. Manzoli L., Ioannidis J.P., Flacco M.E., De Vito C., Villari P. Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses. Human Vaccin Immunother 2012, 8(7):851-862.
24. Tricco A.C., Chit A., Soobiah C., Hallett D., Meier G., Chen M.H., et al. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med 2013, 11:153.
25. Skowronski D.M., Janjua N.Z., De Serres G., Dickinson J.A., Winter A.L., Mahmud S.M., et al. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. Euro Surveill 2013, 18.(5).
26. Sullivan S.G., Komadina N., Grant K., Jelley L., Papadakis G., Kelly H. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: Influences of waning immunity and vaccine match. J Med Virol 2013, 86:1017-1025.